For U.S. veterans with stable angina, the use of community facilities for percutaneous revascularization is associated with increased mortality.
Certain reproductive factors may up the risk for obstructive coronary artery disease (CAD) in postmenopausal women.
Stress cardiac magnetic resonance imaging was found to lead to the reclassification of guideline-evaluated risk for a significant percentage of patients with suspected myocardial ischemia and no history of coronary artery disease.
Eating chocolate at least once a week is associated with a lower risk for coronary artery disease (CAD).
Use of radial artery vs saphenous vein for coronary artery bypass grafting was found to be associated with a reduced long-term risk for a composite of cardiovascular outcomes.
Individuals with CAD who have not experienced a recent CV event are generally considered to have stable CAD.
Current clinical guidelines for the prevention of cardiovascular disease were not found to fully take into account to the polygenicity underlying coronary artery disease susceptibility.
The Food and Drug Administration has approved Brilinta (ticagrelor; AstraZeneca) to reduce the risk of a first myocardial infarction (MI) or stroke in high-risk patients with coronary artery disease (CAD).
High-risk plaque criteria evaluated on computed tomography angiography were found to provide added value for the prediction of long-term outcomes in patients with coronary artery disease.
Study finds no incremental benefit of an percutaneous coronary intervention or coronary artery bypass grafting in patients with stable coronary disease and advanced chronic kidney disease.